Balta et al. endorse the development of AMY-101 for the treatment of periodontitis “Emerging evidence from novel drug candidates, …..and complement inhibitors as previously studied in animal models and currently in human clinical trials, suggests future availability of adjunctive therapeutic strategies for the management of periodontitis”.
Balta MG, Papathanasiou E, Blix IJ, Van Dyke TE. (2021). Host Modulation and Treatment of Periodontal Disease. Journal of Dental Research 100: 798-809.
